Mesothelioma Case Study: Heidi
With combination therapy that included targeted therapy guided by FidoCure® genomic sequencing, Heidi has survived over a year following her initial diagnosis of mesothelioma and is still going strong.
Telangiectatic Osteosarcoma Case Study: Scout
With a combination approach that included FidoCure® therapy, Scout has lived for 1.5 years after his initial diagnosis of telangiectatic osteosarcoma.
Jejunal Adenocarcinoma Case Study: Callie
With surgery and FidoCure® therapy, Callie is alive and well almost 20 months after her initial diagnosis of jejunal adenocarcinoma.
Osteosarcoma Case Study: Jade
With a combination approach that included FidoCure® therapy, Jade is alive and well 2 years after her initial diagnosis of osteosarcoma.
Insulinoma Case Study: Winston
With a combination approach that included FidoCure®, Winston survived two years following his initial diagnosis of metastatic insulinoma.
Splenic Hemangiosarcoma Case Study: Pita
With a combination approach that included FidoCure® therapy, Pita lived for a year following a hemoabdomen and diagnosis of splenic hemangiosarcoma.
Anal Sac Adenocarcinoma Case Study: Brady
Transitional Cell Carcinoma Case Study: Ruby
With the help of FidoCure® therapy, Ruby had a great quality of life for 2 years after her initial diagnosis of transitional cell carcinoma.
Amelanotic Melanoma Case Study: Phinn
With the help of FidoCure® therapy, Phinn has lived a great quality of life for over 18 months after his initial diagnosis of amelanotic melanoma and is still going strong!